{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T18:45:34Z","timestamp":1782672334819,"version":"3.54.5"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.amjmed.2015.12.006","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T12:04:46Z","timestamp":1450958686000},"page":"461-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Preventing and Treating Acute Kidney Injury Among Hospitalized Patients with Cirrhosis and Ascites: A Narrative Review"],"prefix":"10.1016","volume":"129","author":[{"given":"Elliot B.","family":"Tapper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Bonder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Cardenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2015.12.006_bib1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.amjmed.2015.12.006_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.amjmed.2015.12.006_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.mayocp.2015.03.003","article-title":"Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy","volume":"90","author":"Tapper","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjmed.2015.12.006_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib6","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1053\/gast.2002.33575","article-title":"Hepatorenal syndrome in cirrhosis: pathogenesis and treatment","volume":"122","author":"Arroyo","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cgh.2012.10.040","article-title":"Multidisciplinary management of patients with cirrhosis: a need for care coordination","volume":"11","author":"Mellinger","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.amjmed.2015.12.006_bib9","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.510280405","article-title":"Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats","volume":"28","author":"Gupta","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gines","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjmed.2015.12.006_bib11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.amjmed.2015.12.006_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Epstein","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjmed.2015.12.006_bib13","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/gut.25.10.1034","article-title":"Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis","volume":"25","author":"Henriksen","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.amjmed.2015.12.006_bib14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI102813","article-title":"The cardiac output at rest in Laennec's cirrhosis","volume":"32","author":"Kowalski","year":"1953","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.amjmed.2015.12.006_bib15","first-page":"88","article-title":"Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis","volume":"22","author":"M\u00f8ller","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510280337","article-title":"Hyponatremia in cirrhosis: from pathogenesis to treatment","volume":"28","author":"Gines","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib17","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/jhm.1915","article-title":"Hyponatremia in cirrhosis","volume":"7","author":"Sigal","year":"2012","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.amjmed.2015.12.006_bib18","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/hep.26687","article-title":"Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival","volume":"59","author":"Barreto","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.amjmed.2015.12.006_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.amjmed.2015.12.006_bib20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jhm.2314","article-title":"Outcomes associated with a mandatory gastroenterology consultation to improve the quality of care of patients hospitalized with decompensated cirrhosis","volume":"10","author":"Ghaoui","year":"2015","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.amjmed.2015.12.006_bib21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jhm.2275","article-title":"Use of paracentesis in hospitalized patients with decompensated cirrhosis and ascites: Opportunities for quality improvement","volume":"9","author":"Brooling","year":"2014","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.amjmed.2015.12.006_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/liv.12225","article-title":"Measurement of the quality of care of patients admitted with decompensated cirrhosis","volume":"34","author":"Ghaoui","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.amjmed.2015.12.006_bib23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/hep.1840120415","article-title":"Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis","volume":"12","author":"Runyon","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib24","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/ajg.2014.212","article-title":"Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis","volume":"109","author":"Kim","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2015.12.006_bib25","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.3-57.v2","article-title":"The need for antibiotic stewardship and treatment standardization in the care of cirrhotic patients with spontaneous bacterial peritonitis\u2013a retrospective cohort study examining the effect of ceftriaxone dosing","volume":"3","author":"Mazer","year":"2014","journal-title":"F1000Res"},{"key":"10.1016\/j.amjmed.2015.12.006_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.amjmed.2015.12.006_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/acem.12059","article-title":"Risk factors for radiocontrast nephropathy after emergency department contrast-enhanced computerized tomography","volume":"20","author":"Traub","year":"2013","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.amjmed.2015.12.006_bib28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fern\u00e1ndez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11901-014-0217-7","article-title":"Current therapies for hepatorenal syndrome","volume":"13","author":"Bonder","year":"2014","journal-title":"Curr Hepatol Rep"},{"issue":"6","key":"10.1016\/j.amjmed.2015.12.006_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jhm.2325","article-title":"Before you call renal: acute kidney injury for hospitalists","volume":"10","author":"Cooper","year":"2015","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.amjmed.2015.12.006_bib31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A\u00a0modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.amjmed.2015.12.006_bib32","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2215\/CJN.02860608","article-title":"Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients","volume":"3","author":"Perazella","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjmed.2015.12.006_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.amjmed.2015.12.006_bib34","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.amjmed.2015.12.006_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.amjmed.2015.12.006_bib36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/gastro\/gov032","article-title":"The efficacy and safety profile of albumin administration for patients with cirrhosis at high risk of hepatorenal syndrome is dose dependent","volume":"3","author":"Afinogenova","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.amjmed.2015.12.006_bib37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.amjmed.2015.12.006_bib38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0016-5085(83)90133-6","article-title":"Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors","volume":"84","author":"Zipser","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0016-5085(79)90268-3","article-title":"Effect of indomethacin and prostaglandin A, on renal function and plasma renin activity in alcoholic liver disease","volume":"77","author":"Boyer","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2013.09.016","article-title":"The changing role of beta-blocker therapy in patients with cirrhosis","volume":"60","author":"Phillip","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.amjmed.2015.12.006_bib41","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2011.01.034","article-title":"Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study","volume":"55","author":"Serst\u00e9","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.amjmed.2015.12.006_bib42","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serst\u00e9","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.amjmed.2015.12.006_bib43","doi-asserted-by":"crossref","first-page":"1680e1","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective \u03b2 blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"146","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/hep.23852","article-title":"Beta-blockers in cirrhosis: friend and foe?","volume":"52","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.amjmed.2015.12.006_bib46","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1572-0241.2005.40952.x","article-title":"Hepatorenal syndrome: a dreaded complication of end-stage liver disease","volume":"100","author":"C\u00e1rdenas","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2015.12.006_bib47","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib48","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib49","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib50","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib51","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome","volume":"9","author":"Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2015.12.006_bib52","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.amjmed.2015.12.006_bib53","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib54","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.amjmed.2015.12.006_bib55","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhep.2003.50276","article-title":"Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study","volume":"38","author":"Pomier-Layrargues","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2015.12.006_bib56","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome","volume":"52","author":"Esrailian","year":"2007","journal-title":"Dig Dis Sci"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934315300395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934315300395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:28:12Z","timestamp":1762079292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934315300395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0002934315300395"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2015.12.006","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing and Treating Acute Kidney Injury Among Hospitalized Patients with Cirrhosis and Ascites: A Narrative Review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2015.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}